Serilink Biotechnology Company Limited
Room 01, 6/F, Building 6W & S35, S36, 6/F, Building 17W
No.6 & No.17 Science Park West Avenue
Hong Kong Science Park,Pak Shek Kok,N.T.
+852 96473402
Ms. Hoi Yee Chow
The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
Serilink specializes in the synthesis and modification of peptide/protein drugs and bioconjugations between small molecules and bio-macromolecules, by utilizing our in-house-developed patented novel technology (OPA LinkTech). We are focused on building a high-tech biologic therapeutics research platform for developing antibody-drug conjugates (ADCs), antibody-radionuclide conjugates (ARCs) and peptide-drug conjugates (PDCs).
Our main solutions: Small molecule synthesis, peptide/protein drug chemical synthesis and modifications, conjugation (covalent linkage) between biomacromolecules and small molecules, peptide-drug conjugates.